258 related articles for article (PubMed ID: 32538722)
1. Gut Barrier Proteins Mediate Liver Regulation by the Effects of Serotonin on the Non-Alcoholic Fatty Liver Disease.
Zhang K; Li X; Wang X; Zheng H; Tang S; Lu L; Ma X
Curr Protein Pept Sci; 2020; 21(10):978-984. PubMed ID: 32538722
[TBL] [Abstract][Full Text] [Related]
2. Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice.
Ritze Y; Bárdos G; Hubert A; Böhle M; Bischoff SC
Br J Nutr; 2014 Jul; 112(1):1-7. PubMed ID: 24708895
[TBL] [Abstract][Full Text] [Related]
3. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.
Haub S; Kanuri G; Volynets V; Brune T; Bischoff SC; Bergheim I
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G335-44. PubMed ID: 19713474
[TBL] [Abstract][Full Text] [Related]
4. Serotonin signals through a gut-liver axis to regulate hepatic steatosis.
Choi W; Namkung J; Hwang I; Kim H; Lim A; Park HJ; Lee HW; Han KH; Park S; Jeong JS; Bang G; Kim YH; Yadav VK; Karsenty G; Ju YS; Choi C; Suh JM; Park JY; Park S; Kim H
Nat Commun; 2018 Nov; 9(1):4824. PubMed ID: 30446669
[TBL] [Abstract][Full Text] [Related]
5. Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice.
Ritze Y; Böhle M; Haub S; Hubert A; Enck P; Zipfel S; Bischoff SC
BMC Gastroenterol; 2013 Dec; 13():169. PubMed ID: 24321090
[TBL] [Abstract][Full Text] [Related]
6. Enteric serotonin and oxytocin: endogenous regulation of severity in a murine model of necrotizing enterocolitis.
Gross Margolis K; Vittorio J; Talavera M; Gluck K; Li Z; Iuga A; Stevanovic K; Saurman V; Israelyan N; Welch MG; Gershon MD
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G386-G398. PubMed ID: 28774871
[TBL] [Abstract][Full Text] [Related]
7. Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.
Haub S; Ritze Y; Ladel I; Saum K; Hubert A; Spruss A; Trautwein C; Bischoff SC
J Pharmacol Exp Ther; 2011 Dec; 339(3):790-8. PubMed ID: 21903748
[TBL] [Abstract][Full Text] [Related]
8. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats.
Zhao ZH; Xin FZ; Xue Y; Hu Z; Han Y; Ma F; Zhou D; Liu XL; Cui A; Liu Z; Liu Y; Gao J; Pan Q; Li Y; Fan JG
Exp Mol Med; 2019 Sep; 51(9):1-14. PubMed ID: 31506421
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Gut Microbiota Composition by Serotonin Signaling Influences Intestinal Immune Response and Susceptibility to Colitis.
Kwon YH; Wang H; Denou E; Ghia JE; Rossi L; Fontes ME; Bernier SP; Shajib MS; Banskota S; Collins SM; Surette MG; Khan WI
Cell Mol Gastroenterol Hepatol; 2019; 7(4):709-728. PubMed ID: 30716420
[TBL] [Abstract][Full Text] [Related]
10. Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver.
Ko M; Kamimura K; Owaki T; Nagoya T; Sakai N; Nagayama I; Niwa Y; Shibata O; Oda C; Morita S; Kimura A; Inoue R; Setsu T; Sakamaki A; Yokoo T; Terai S
Dis Model Mech; 2021 Mar; 14(3):. PubMed ID: 33787507
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract.
Gershon MD
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):14-21. PubMed ID: 23222853
[TBL] [Abstract][Full Text] [Related]
12. Properties of myenteric neurones and mucosal functions in the distal colon of diet-induced obese mice.
Reichardt F; Baudry C; Gruber L; Mazzuoli G; Moriez R; Scherling C; Kollmann P; Daniel H; Kisling S; Haller D; Neunlist M; Schemann M
J Physiol; 2013 Oct; 591(20):5125-39. PubMed ID: 23940384
[TBL] [Abstract][Full Text] [Related]
13. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065
[TBL] [Abstract][Full Text] [Related]
14. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
15. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
[TBL] [Abstract][Full Text] [Related]
16. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons.
Li Z; Chalazonitis A; Huang YY; Mann JJ; Margolis KG; Yang QM; Kim DO; Côté F; Mallet J; Gershon MD
J Neurosci; 2011 Jun; 31(24):8998-9009. PubMed ID: 21677183
[TBL] [Abstract][Full Text] [Related]
17. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells.
Reigstad CS; Salmonson CE; Rainey JF; Szurszewski JH; Linden DR; Sonnenburg JL; Farrugia G; Kashyap PC
FASEB J; 2015 Apr; 29(4):1395-403. PubMed ID: 25550456
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis.
Crane JD; Palanivel R; Mottillo EP; Bujak AL; Wang H; Ford RJ; Collins A; Blümer RM; Fullerton MD; Yabut JM; Kim JJ; Ghia JE; Hamza SM; Morrison KM; Schertzer JD; Dyck JR; Khan WI; Steinberg GR
Nat Med; 2015 Feb; 21(2):166-72. PubMed ID: 25485911
[TBL] [Abstract][Full Text] [Related]
19. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
20. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine.
Brandt A; Hernández-Arriaga A; Kehm R; Sánchez V; Jin CJ; Nier A; Baumann A; Camarinha-Silva A; Bergheim I
Sci Rep; 2019 Apr; 9(1):6668. PubMed ID: 31040374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
